title: A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes.
abstract: The actions of the RIG-I like receptor (RLR) and type I interferon (IFN) signaling pathways are essential for a protective innate immune response against the emerging flavivirus West Nile virus (WNV). In mice lacking RLR or IFN signaling pathways, WNV exhibits enhanced tissue tropism, indicating that specific host factors of innate immune defense restrict WNV infection and dissemination in peripheral tissues. However, the immune mechanisms by which the RLR and IFN pathways coordinate and function to impart restriction of WNV infection are not well defined. Using a systems biology approach, we defined the host innate immune response signature and actions that restrict WNV tissue tropism. Transcriptional profiling and pathway modeling to compare WNV-infected permissive (spleen) and nonpermissive (liver) tissues showed high enrichment for inflammatory responses, including pattern recognition receptors and IFN signaling pathways, that define restriction of WNV replication in the liver. Assessment of infected livers from Mavs(-/-) × Ifnar(-/-) mice revealed the loss of expression of several key components within the natural killer (NK) cell signaling pathway, including genes associated with NK cell activation, inflammatory cytokine production, and NK cell receptor signaling. In vivo analysis of hepatic immune cell infiltrates from WT mice demonstrated that WNV infection leads to an increase in NK cell numbers with enhanced proliferation, maturation, and effector action. In contrast, livers from Mavs(-/-) × Ifnar(-/-) infected mice displayed reduced immune cell infiltration, including a significant reduction in NK cell numbers. Analysis of cocultures of dendritic and NK cells revealed both cell-intrinsic and -extrinsic roles for the RLR and IFN signaling pathways to regulate NK cell effector activity. Taken together, these observations reveal a complex innate immune signaling network, regulated by the RLR and IFN signaling pathways, that drives tissue-specific antiviral effector gene expression and innate immune cellular processes that control tissue tropism to WNV infection.
authors.affiliation: Department of Immunology, University of Washington School of Medicine, Seattle, Washington, USA.
authors.forename: Mehul S
authors.initials: MS
authors.lastname: Suthar
authors.forename: Margaret M
authors.initials: MM
authors.lastname: Brassil
authors.forename: Gabriele
authors.initials: G
authors.lastname: Blahnik
authors.forename: Aimee
authors.initials: A
authors.lastname: McMillan
authors.forename: Hilario J
authors.initials: HJ
authors.lastname: Ramos
authors.forename: Sean C
authors.initials: SC
authors.lastname: Proll
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Belisle
authors.forename: Michael G
authors.initials: MG
authors.lastname: Katze
authors.forename: Michael
authors.initials: M
authors.lastname: Gale
mesh_terms: D000818:Animals; D053263:Gene Regulatory Networks / Q000276:immunology; D005796:Genes / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular / Q000235:genetics*; D007113:Immunity, Innate / Q000235:genetics*; D007370:Interferon Type I / Q000378:metabolism / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology; D049490:Systems Biology / Q000379:methods; D056189:Viral Tropism / Q000235:genetics*; D014901:West Nile Fever / Q000235:genetics / Q000276:immunology*; D014902:West Nile virus / Q000276:immunology* / Q000502:physiology*
chemical_list: D007370:Interferon Type I; D011971:Receptors, Immunologic
references.citation: Virology. 2011 Jan 20;409(2):262-70
references.pmid: 21056894
references.citation: Nat Protoc. 2009;4(1):44-57
references.pmid: 19131956
references.citation: J Virol. 2010 Dec;84(23):12125-38
references.pmid: 20881045
references.citation: PLoS One. 2010 Nov 15;5(11):e13984
references.pmid: 21085593
references.citation: J Immunol Methods. 2004 Nov;294(1-2):15-22
references.pmid: 15604012
references.citation: PLoS Pathog. 2009 Oct;5(10):e1000607
references.pmid: 19798431
references.citation: J Virol. 2007 Jan;81(2):860-71
references.pmid: 17079283
references.citation: Immunity. 2012 Aug 24;37(2):235-48
references.pmid: 22841161
references.citation: J Virol. 2012 Jul;86(14):7704-9
references.pmid: 22573862
references.citation: J Exp Med. 2009 Dec 21;206(13):2967-76
references.pmid: 19995959
references.citation: Nature. 2011 Apr 28;472(7344):481-5
references.pmid: 21478870
references.citation: J Virol. 2008 Sep;82(17):8465-75
references.pmid: 18562536
references.citation: Virology. 2007 Nov 25;368(2):422-30
references.pmid: 17675128
references.citation: J Virol. 2011 Nov;85(22):11557-66
references.pmid: 21880757
references.citation: J Virol. 2008 Nov;82(22):10964-74
references.pmid: 18786989
references.citation: J Virol. 2008 Jan;82(1):335-45
references.pmid: 17942531
references.citation: J Virol. 2009 Aug;83(16):8276-81
references.pmid: 19494017
references.citation: J Immunol. 2006 Mar 15;176(6):3315-9
references.pmid: 16517698
references.citation: Cell. 1990 Jul 13;62(1):51-61
references.pmid: 2194673
references.citation: Curr Opin Immunol. 2003 Feb;15(1):45-51
references.pmid: 12495732
references.citation: mBio. 2011 Aug 09;2(4):
references.pmid: 21828218
references.citation: J Immunol. 2009 Aug 15;183(4):2610-21
references.pmid: 19635919
references.citation: J Virol. 2006 Jun;80(11):5338-48
references.pmid: 16699014
references.citation: Immunity. 2009 Feb 20;30(2):242-53
references.pmid: 19200759
references.citation: FASEB J. 2012 Mar;26(3):1290-300
references.pmid: 22106366
references.citation: PLoS Pathog. 2011 Dec;7(12):e1002407
references.pmid: 22144897
references.citation: J Virol. 2006 Oct;80(19):9424-34
references.pmid: 16973548
references.citation: J Virol. 2010 Aug;84(16):8332-41
references.pmid: 20534863
references.citation: Nature. 2010 Nov 18;468(7322):452-6
references.pmid: 21085181
references.citation: J Virol. 2003 Dec;77(24):13323-34
references.pmid: 14645588
references.citation: Nat Immunol. 2005 Oct;6(10):1011-9
references.pmid: 16142239
references.citation: Nature. 2008 Jul 24;454(7203):523-7
references.pmid: 18548002
references.citation: J Virol. 2006 Jul;80(14):7009-19
references.pmid: 16809306
references.citation: PLoS Pathog. 2012;8(5):e1002698
references.pmid: 22589727
references.citation: J Virol. 2005 Nov;79(21):13350-61
references.pmid: 16227257
references.citation: J Immunol. 2006 Aug 1;177(3):1746-54
references.pmid: 16849484
references.citation: PLoS Pathog. 2010 Feb 05;6(2):e1000757
references.pmid: 20140199
references.citation: J Biol Chem. 2011 Dec 30;286(52):44412-23
references.pmid: 22065572
references.citation: Curr Opin Virol. 2011 Sep;1(3):167-76
references.pmid: 21949557
references.citation: J Virol. 2011 May;85(10):5197-201
references.pmid: 21367890
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1371-6
references.pmid: 17227866
references.citation: BMC Immunol. 2010 Jan 20;11:3
references.pmid: 20089143
references.citation: J Immunol. 2005 Jan 15;174(2):727-34
references.pmid: 15634892
references.citation: J Immunol. 2009 Aug 15;183(4):2522-8
references.pmid: 19635904
references.citation: Eur J Immunol. 2006 Aug;36(8):2094-105
references.pmid: 16810635
references.citation: Virol J. 2011 Oct 13;8:468
references.pmid: 21992229
references.citation: Gut. 2011 Feb;60(2):268-78
references.pmid: 20876777
references.citation: J Immunol. 2006 Apr 1;176(7):4343-51
references.pmid: 16547272
references.citation: Arch Virol. 2005 Jun;150(6):1213-20
references.pmid: 15717119
references.citation: Nucleic Acids Res. 2009 Jan;37(1):1-13
references.pmid: 19033363
references.citation: Curr Opin Microbiol. 2010 Aug;13(4):530-9
references.pmid: 20558100
references.citation: Transpl Infect Dis. 2011 Jun;13(3):312-7
references.pmid: 21235711
references.citation: PLoS Pathog. 2012;8(5):e1002712
references.pmid: 22615570
references.citation: J Clin Immunol. 2009 May;29(3):265-73
references.pmid: 19280325
references.citation: J Leukoc Biol. 2011 Feb;89(2):189-94
references.pmid: 20682623
references.citation: J Virol. 2006 Oct;80(19):9349-60
references.pmid: 16973541
references.citation: Cell. 2009 Dec 24;139(7):1243-54
references.pmid: 20064371
references.citation: J Virol. 2008 Nov;82(21):10349-58
references.pmid: 18715906
references.citation: J Immunol. 2005 Sep 15;175(6):3946-54
references.pmid: 16148142
references.citation: J Virol. 2006 Jan;80(1):119-29
references.pmid: 16352536
references.citation: PLoS Pathog. 2009 Oct;5(10):e1000610
references.pmid: 19816558
references.citation: Nat Immunol. 2008 May;9(5):503-10
references.pmid: 18425107
references.citation: J Virol. 2008 Jan;82(2):609-16
references.pmid: 17977974
references.citation: J Exp Med. 2005 Sep 5;202(5):637-50
references.pmid: 16129706